Is Weakness In BioNTech SE (NASDAQ:BNTX) Stock A Sign That …

Apr 15, 2023 · With its stock down 11% over the past three months, it is easy to disregard BioNTech (NASDAQ:BNTX). However, stock prices are usually driven by a company’s financial performance over the long ...

11%
OFF

Is Weakness In BioNTech SE (NASDAQ:BNTX) Stock A Sign That …

2 weeks from now

yahoo.com

19%
OFF

Is Weakness In BioNTech SE (NASDAQ:BNTX) Stock A Sign That …

2 weeks from now

Jan 23, 2023 · With its stock down 19% over the past month, it is easy to disregard BioNTech (NASDAQ:BNTX). But if you pay close attention, you might gather that its strong financials …

yahoo.com

3%
OFF

BioNTech (NASDAQ:BNTX) Stock Price Down 1.3% - What's Next?

2 weeks from now

Dec 18, 2024 · Shares of BioNTech SE (NASDAQ:BNTX - Get Free Report) dropped 1.3% on Wednesday . The stock traded as low as $115.51 and last traded at $115.91. Approximately …

marketbeat.com

28%
OFF

Is Weakness In BioNTech SE (NASDAQ:BNTX) Stock A Sign That …

2 weeks from now

Mar 13, 2023 · BioNTech (NASDAQ:BNTX) has had a rough three months with its share price down 28%. However, a closer look at its sound financials might cause you to think again. …

statfolio.net

$117
OFF

Why BioNTech (BNTX) Shares Are Volatile Today - Benzinga

2 weeks from now

3 days ago · In the case of BioNTech, which is trading at $117.8 as of publishing time, $100 would buy you 0.85 shares of stock. If you're looking to bet against a company, the process is …

benzinga.com

28%
OFF

Is Weakness In BioNTech SE (NASDAQ:BNTX) Stock A Sign That …

2 weeks from now

Mar 13, 2023 · BioNTech (NASDAQ:BNTX) has had a rough three months with its share price down 28%. ... Is Weakness In BioNTech SE (NASDAQ:BNTX) Stock A Sign That The Market …

yahoo.com

$145.00
OFF

Morgan Stanley Sticks To Its Buy Rating For BioNTech SE (BNTX)

2 weeks from now

Jan 6, 2025 · Morgan Stanley analyst Terence Flynn maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of $145.00.The company’s shares …

businessinsider.com

5%
OFF

Will Weakness In BioNTech SE's (NASDAQ:BNTX) Stock Prove …

2 weeks from now

Mar 11, 2024 · With its stock down 7.5% over the past three months, it is easy to disregard BioNTech (NASDAQ:BNTX). However, stock prices are usually driven by a company’s …

yahoo.com

40%
OFF

Truist Rates BioNTech A Buy, Citing 40% Upside ... - Investing.com

2 weeks from now

6 days ago · On Friday, Truist Securities began coverage on BioNTech shares (NASDAQ: BNTX) with a Buy rating, accompanied by a price target set at $172.00.The securities firm's analysis …

investing.com

$120.38
OFF

BioNTech (BNTX) Stock Forecast And Price Target 2025 - MarketBeat

2 weeks from now

6 days ago · The stock is currently trading at $120.38, which is below its 52-week high of $131.49, indicating potential for price appreciation as it approaches previous highs. With a market …

marketbeat.com

27%
OFF

BioNTech SE (NASDAQ:BNTX) Shares Fly 27% But Investors Aren't …

2 weeks from now

Sep 13, 2024 · BioNTech SE (NASDAQ:BNTX) shares have had a really impressive month, gaining 27% after a shaky period beforehand. The bad news is that even after the stocks …

simplywall.st

6%
OFF

Why BioNTech Stock Is Sinking Today - Nasdaq

2 weeks from now

May 4, 2021 · What happened. Shares of BioNTech (NASDAQ: BNTX) were trading down by 17.6% as of 11:50 a.m. EDT on Tuesday. The German biotech didn't announce any news that …

nasdaq.com

FAQs about Is Weakness In BioNTech SE (NASDAQ:BNTX) Stock A Sign That … Coupon?

Is biontech se a good stock to buy?

BioNTech SE has an analyst consensus of Strong Buy, with a price target consensus of $141.61, representing a 22.30% upside. In a report released on December 19, Jefferies also maintained a Buy rating on the stock with a €149.00 price target. ...

Is biontech (bntx) a good stock to buy?

BioNTech (NASDAQ:BNTX) has had a rough three months with its share price down 28%. However, a closer look at its sound financials might cause you to think again. Given that fundamentals usually drive long-term market outcomes,the company is worth looking at. In this article, we decided to focus on BioNTech's ROE. ...

What is the average price target for biontech (bntx)?

According to the 14 analysts' twelve-month price targets for BioNTech, the average price target is $135.54. The highest price target for BNTX is $171.00, while the lowest price target for BNTX is $100.00. The average price target represents a forecasted upside of 22.24% from the current price of $110.88. ...

Who invests in biontech?

BioNTech's top institutional investors include GAMMA Investing LLC. How do I buy shares of BioNTech? Shares of BNTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. ...

Will biontech SE meet market expectations?

BioNTech SE's recent earnings per share (EPS) results have fallen short of consensus estimates, raising concerns about its ability to meet market expectations. The company's revenue for the quarter was down 23.3% year-over-year, reflecting a decline in sales that may affect future profitability and investor confidence. ...

Is biontech a good news company?

BioNTech has a news sentiment score of 1.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Medical companies. ...